Concepedia

David K. Leahy

DK

Statistics

Publications

33

Citations

1.8K

H-Index

20

Active since

2000

Affiliations

Bristol-Myers Squibb (United States)(Current)

Takeda (United States)

Indiana University Bloomington

Merck & Co., Inc., Rahway, NJ, USA (United States)

Eli Lilly (United States)

David K. Leahy is an author at Bristol-Myers Squibb (United States) specializing in natural sciences, chemistry, and catalysis.

Publications per year

2000–2023

33

Publications

33

A Pharmaceutical Industry Perspective on Sustainable Metal Catalysis

John Hayler, David K. Leahy, Eric M. Simmons · Organometallics · 2018 · 318 citations

Natural Sciences, Chemical Engineering, Chemistry +17

Regio- and Enantiospecific Rhodium-Catalyzed Allylic Etherification Reactions Using Copper(I) Alkoxides: Influence of the Copper Halide Salt on Selectivity

P. Andrew Evans, David K. Leahy · Journal of the American Chemical Society · 2002 · 148 citations

Natural Sciences, Chemical Engineering, Chemistry +17

Regioselective and Enantiospecific Rhodium-Catalyzed Intermolecular Allylic Etherification with Ortho-Substituted Phenols

P. Andrew Evans, David K. Leahy · Journal of the American Chemical Society · 2000 · 133 citations

Natural Sciences, Biochemistry, Chemistry +6

A deeper shade of green: inspiring sustainable drug manufacturing

Frank Roschangar, Juan Colberg, Peter J. Dunn et al. · Green Chemistry · 2016 · 119 citations

Engineering, Environmental Management, Sustainability Management +17

Catalytic asymmetric and stereodivergent oligonucleotide synthesis

Aaron L. Featherston, Yongseok Kwon, Matthew Pompeo et al. · Science · 2021 · 104 citations · Full text

Pharmacy, Biochemistry, Chemistry +14

1–5 of 33